Aditxt, Inc. Stock-Based Compensation
Aditxt, Inc. (ADTX) reported Stock-Based Compensation of $473.31 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-31
- Aditxt, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $4.37K, a 99.41% decline year-over-year.
- Aditxt, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $32.00, a 99.98% decline year-over-year.
- Aditxt, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $473.31K, a 1331.20% increase from fiscal 2024.
- Aditxt, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $33.07K, a 97.64% decline from fiscal 2023.
- Aditxt, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.40M, a 55.23% decline from fiscal 2022.
- Aditxt, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $3.13M, a 32.52% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $473.31K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $473.31K 10-Q · filed 2025-11-18 | ||
| 2025-06-30 | $473.31K 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $4.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.40K derived: sum of 2 quarters · filed 2026-03-31 | $8.50K derived: sum of 3 quarters · filed 2026-03-31 | $33.07K 10-K · filed 2026-03-31 |
| 2024-09-30 | $32.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $4.13K derived: sum of 2 quarters · filed 2025-11-18 | $28.70K 10-Q · filed 2025-11-18 | $774.05K derived: sum of 4 quarters · filed 2025-11-18 |
| 2024-06-30 | $4.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $28.67K 10-Q · filed 2025-08-14 | $774.02K derived: sum of 3 quarters · filed 2025-08-14 | $928.01K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $24.57K 10-Q · filed 2025-05-15 | $769.92K derived: sum of 2 quarters · filed 2025-05-15 | $923.91K derived: sum of 3 quarters · filed 2025-05-15 | $1.09M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $745.35K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $899.34K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M derived: sum of 3 quarters · filed 2025-03-31 | $1.40M 10-K · filed 2025-03-31 |
| 2023-09-30 | $153.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $317.22K derived: sum of 2 quarters · filed 2024-11-18 | $656.67K 10-Q · filed 2024-11-18 | $1.27M derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-06-30 | $163.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $502.68K 10-Q · filed 2024-08-19 | $1.12M derived: sum of 3 quarters · filed 2024-08-19 | $1.75M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $339.45K 10-Q · filed 2024-05-20 | $953.70K derived: sum of 2 quarters · filed 2024-05-20 | $1.59M derived: sum of 3 quarters · filed 2024-05-20 | $2.87M derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $614.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.25M derived: sum of 2 quarters · filed 2024-04-16 | $2.53M derived: sum of 3 quarters · filed 2024-04-16 | $3.13M 10-K · filed 2024-04-16 |
| 2022-09-30 | $631.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.92M derived: sum of 2 quarters · filed 2023-11-14 | $2.52M 10-Q · filed 2023-11-14 | $4.02M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.89M 10-Q · filed 2023-08-14 | $3.39M derived: sum of 3 quarters · filed 2023-08-14 | $4.29M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $601.27K 10-Q · filed 2023-05-15 | $2.11M derived: sum of 2 quarters · filed 2023-05-15 | $3.00M derived: sum of 3 quarters · filed 2023-05-15 | $3.78M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $2.40M derived: sum of 2 quarters · filed 2023-04-17 | $3.18M derived: sum of 3 quarters · filed 2023-04-17 | $4.64M 10-K · filed 2023-04-17 |
| 2021-09-30 | $899.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.67M derived: sum of 2 quarters · filed 2022-11-14 | $3.14M 10-Q · filed 2022-11-14 | $4.76M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $772.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.24M 10-Q · filed 2022-08-15 | $3.86M derived: sum of 3 quarters · filed 2022-08-15 | $4.74M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.46M 10-Q · filed 2022-05-16 | $3.09M derived: sum of 2 quarters · filed 2022-05-16 | $3.96M derived: sum of 3 quarters · filed 2022-05-16 | $4.12M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.50M derived: sum of 2 quarters · filed 2022-03-31 | $2.66M derived: sum of 3 quarters · filed 2022-03-31 | $3.19M 10-K · filed 2022-03-31 |
| 2020-09-30 | $874.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.03M derived: sum of 2 quarters · filed 2021-11-15 | $1.56M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $160.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $689.77K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $529.44K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $3.70M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |